Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
14NOV

Founders' relief built for 600 a year

3 min read
18:53UTC

The Budget's new 10% founders' tax rate is expected to reach about 600 people a year, while the relief most business sellers use was halved. The National Wealth Fund put £113m into Uforce and state money joined Fractile's $720m round, in the same fortnight Sequoia shut its London office.

Key takeaway

Britain's new founder tax break and its state funds both target companies that have already scaled.

This briefing mapped
Economic
Competitive

John Healey's Budget cut capital gains tax to 10% for founders, but HM Treasury expects only about 600 people a year to qualify, and the older relief for business sellers shrinks from the same day.

Sources profile:This story draws on neutral-leaning sources

Chancellor John Healey's Budget on 28 October brought back a 10% capital gains rate for founders, on up to £10m of lifetime gains. The Treasury expects about 600 people a year to qualify, because the company must already have £10m of turnover and 15 staff.

Ordinary sellers lose ground at the same time. Business Asset Disposal Relief now covers only £500,000 of gains, and comments on the new rules close on 30 November. 

The National Wealth Fund co-led Uforce's $700m Series A with £113m, two weeks after Healey told it to focus on defence.

Sources profile:This story draws on neutral-leaning sources

Fractile, which has not yet shipped a chip, raised a $720m Series C led by Thrive Capital, with the British Business Bank and an unnamed "SovAI" new to its register.

Sources profile:This story draws on neutral-leaning sources

Nscale's amended US listing filing puts $3.22bn on the Loughton statement of work with Microsoft and admits no financing is yet committed for its Anthropic campus.

Sources profile:This story draws on neutral-leaning sources

Nscale filed its first amended US listing document on 12 November, still with no share price range. It values the Microsoft work at Loughton, Essex, which ended in October, at $3.22bn.

The filing blames the local power provider, which withdrew the site's grid connection date. Nscale also says it has no binding financing yet for its $44.6bn Anthropic campus in West Virginia. 

Sequoia Capital is closing the London office it opened in 2020, with its Arc and Scouts programmes, and will back European founders from the Bay Area.

Sources profile:This story draws on mixed-leaning sources from United States
United States

Sequoia Capital said on 4 November it will close the London office it opened in 2020. It is also ending Arc and Scouts, its two programmes for finding very early founders.

Partner Luciana Lixandru stays in Europe, but the firm will back European companies from the Bay Area. Andreessen Horowitz left London in 2025 and Coatue in 2024, so three big American funds have now gone. 

The British Business Bank put £15m into Cambridge spinout T-Therapeutics' $133m Series B and took a board seat beside co-lead Advent Life Sciences.

Sources profile:This story draws on neutral-leaning sources

T-Therapeutics, a University of Cambridge spinout, raised $133m on 5 November. Advent Life Sciences and the British Business Bank co-led it, and the Bank put in £15m for a board seat.

The money takes two drugs towards first human results, one for cancer and one for autoimmune disease. Neither drug has yet been tested in people, and the company has not named their targets. 

Cambridge chip startup Tendrils Compute has closed a seed round reported at about $30m, led by Benchmark, a venture firm that rarely backs hardware.

Sources profile:This story draws on neutral-leaning sources

Oyster Therapeutics, formerly Kesmalea, closed a $60m Series A led by 4BIO Capital, with Eli Lilly joining as a new strategic investor.

Sources profile:This story draws on neutral-leaning sources

Oyster Therapeutics, the British company formerly called Kesmalea, closed a $60m Series A on 10 November. London's 4BIO Capital led it, and Eli Lilly joined as a new investor.

Oyster is building drugs that make brain cells destroy tau, the protein that tangles in Alzheimer's disease. Lilly backed T-Therapeutics five days earlier, both times behind a specialist lead. 

Companies House filings show administrators appointed to Bristol hand-tracking company Ultraleap and its parent, Luminary Roli.

Sources profile:This story draws on neutral-leaning sources

Ultraleap, the Bristol company that tracks hand movements for virtual reality and screens, is in administration. Notices filed at Companies House on 2 and 3 November also cover its parent, Luminary Roli.

Ultraleap was formed in 2019 when Bristol's Ultrahaptics bought Leap Motion, a Californian hand-tracking pioneer. The administrators will now try to sell its patents and business to repay creditors. 

The Scottish National Investment Bank launched its first fund, the £65m Scottish Universities Fund, to back spinouts from Scottish universities.

Sources profile:This story draws on neutral-leaning sources

The Scottish National Investment Bank launched a £65m fund for university spinouts on 10 November, its first fund of this kind. About £15m goes to the earliest rounds and the rest to later ones.

No manager has been named, and investing is not expected to start until spring 2027. The idea came from Scotland's National Innovation Strategy, co-written by Sir Jim McDonald. 

London banking-as-a-service company Griffin raised a $20m Series B led by Octagon Partners, valuing it above $100m.

Sources profile:This story draws on neutral-leaning sources

Griffin, a London bank that supplies accounts to other financial companies, raised a $20m Series B led by Octagon Partners on 12 November. The round values it above $100m.

Griffin says more than 80 companies run on its banking licence, which it won in 2024. The money pays for card issuing and stablecoin services and, it says, gets the bank to profit. 

Sources:Griffin
Closing comments

Up. The National Wealth Fund and British Business Bank are to make up to £5bn available over four years for defence and dual-use technology, so a third National Wealth Fund defence investment after Rowden Technologies and Uforce is the next marker. The Founders' Relief tests can still change before the consultation closes on 30 November.

Different Perspectives
HM Treasury
HM Treasury
The Treasury created a 10% Founders' Relief on up to £10m of lifetime gains and expects about 600 people a year to use it. It says the relief rewards founders behind the UK's fastest-growing companies.
Startup Coalition
Startup Coalition
The founder lobby group welcomed the Budget package for startups. It treats the new relief as the strongest government support for founders in years.
techUK
techUK
The trade body set the new relief against the BADR cut, which halves the most a seller can save to £30,000. It says the Budget takes back with BADR part of what it gives founders.
Tax Justice UK
Tax Justice UK
The campaign group opposed the 10% founders' rate as a giveaway to a small group of wealthy owners. It said the BADR cut should have gone further, to abolition.
Association of Investment Companies (Richard Stone)
Association of Investment Companies (Richard Stone)
The trust industry body criticised the Budget for leaving Venture Capital Trust relief at 20%. It had lobbied for the 30% rate to return.